Watch Demo

Portugal Antidiabetics Industry Outlook 2024 - 2028

See how Portugal Antidiabetics performed compared to key markets such as Canada, Italy and Australia.

Key Market Indicators

**Portuguese Diabetes Medicine Market to Hit $670 Million by 2028** The Portuguese diabetes medicine market is projected to reach approximately $670 million by 2028, up from $560 million in 2023. This reflects an average annual growth rate of 2.7%. Since 2005, the market has seen a robust annual increase of 8.2%. In 2023, Portugal ranked fifth globally in diabetes medicine sales, with Croatia surpassing it at $564 million. Italy, Australia, and Croatia took the second, third, and fourth spots, respectively. **Insulin Exports and Imports on the Rise** Portugal's insulin exports are expected to climb to nearly $2.3 million by 2028, from about $2.2 million in 2023, showing an average annual growth rate of 0.7%. Since 1993, the country's insulin supply has grown by 5.4% annually. In 2023, Portugal ranked 24th in insulin exports, with Barbados leading at $2.2 million. France, Italy, and China occupied the second, third, and fourth positions, respectively. On the import front, Portugal's insulin imports are set to reach around $33 million by 2028, up from $31.6 million in 2023, growing at an annual rate of 0.6%. Since 1993, the demand for insulin in Portugal has remained stable.

Marketing Banner

Portugal Antidiabetics Market Data and Forecasts

How much will Portugal Antidiabetics Market grow to 2028?

Forecast: Import of Insulin in Dosage Forms to Portugal
Forecast: Export of Insulin from Portugal
Forecast: Export of Insulin in Dosage Forms from Portugal
Forecast: Import of Insulin Not in Dosage Forms to Portugal
More in Antidiabetics Industry for 2028